851 Broken Sound Pkwy NW #215
65 articles with Sensus Healthcare
Sensus Healthcare, Inc. announced that Joe Sardano, CEO of the Company, will present a corporate overview at the 20th Annual B. Riley FBR Investor Conference on Thursday, May 23 at 11:00 a.m. Pacific time.
Sensus Healthcare, Inc. announces financial results for the three months ended March 31, 2019.
Sensus Healthcare, Inc., a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement for Brachytherapy Products with Premier.
Sensus Healthcare to Host First Quarter 2019 Financial Results and Business Update Conference Call on May 9, 2019
Sensus Healthcare, Inc. announces that management will hold a conference call on Thursday, May 9, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter ended March 31, 2019.
Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World's First Sculptura™ Intraoperative Radiation Therapy System
Sensus Healthcare, Inc. (NASDAQ: SRTS), today announced that the Company has signed a research and development agreement with the Perelman School of Medicine at the University of Pennsylvania to collaborate with the radiation oncology department on clinical research and development for Sensus' Sculptura
Sensus Healthcare, Inc. announced that Joe Sardano, CEO of the Company, will present a corporate overview at the 31st Annual ROTH Conference on Tuesday, March 19 at 3:30 p.m. Pacific time.
New Online Portal System to Offer Training and Education Related to SRT Devices and Technology
3/8/2019Perhaps the biggest mover and shaker announcement this week was the unexpected resignation of Scott Gottlieb, commissioner of the U.S. Food and Drug Administration. Gottlieb will leave his post later this month to spend more time with his family.
A Single Treatment during Surgery, Sculptura™ Eliminates Weeks of Post-Operative Radiation for Cancer Patients
Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth
Sensus Healthcare, Inc. announces financial results for the three and 12 months ended December 31, 2018.
Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radiation Therapy to Treat Non-Melanoma Skin Cancers and Keloids
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloid scars with Image-Guided Superficial Radiation Therapy (IGSRT), announced today the publication of consensus guidelines on the use of Superficial Radiation Therapy
Sensus Healthcare to Host Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference Call on February 14, 2019
Sensus Healthcare, Inc. announces that management will hold a conference call on Thursday, February 14, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and full year ended December 31, 2018.
Sensus Healthcare Announces Low 3% Keloid Recurrence in Multicenter Case Series of 297 Patients Treated with Superficial Radiation Therapy
SRT-100, a Low-energy X-ray Technology, Used at Site of Keloidectomy Treatment
Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars
Dr. Kenrick Spence of Hillcrest Plastic Surgery in Orlando First to Offer System
Sensus Healthcare, Inc. announces financial results for the three and nine months ended September 30, 2018.
Sensus Healthcare to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 1, 2018
Management will also provide a business update and a discussion on recent and upcoming milestones.
Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel's Largest Hospital for Skin Cancer and Keloid Treatment
SRT-100 Vision Coming to Patients at Sheba Medical Center Near Tel Aviv
South Florida Business Journal Recognizes Sensus Healthcare's Chief Technology Officer at 2018 Technology Awards
Sensus Healthcare, Inc. today announced that the South Florida Business Journal has recognized the Company's Chief Technology Officer, Kal Fishman, as a finalist at this year's Technology Awards. The ceremony was held on Thursday, Oct. 11, 2018, at the Signature Grand in Davie, Fla.
Sensus Healthcare (Nasdaq: SRTS) announced today that it completed a public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share.
Sensus Healthcare, Inc. announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public offering price of $6.80 per share.